News

Thousands of allergy pills recalled

Thousands of allergy pills recalled

RECALLED:Nearly 30,000 allergy tablets are being recalled. Photo: Reuters

MUMBAI (Reuters) – Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.

The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy’s Ohm Labs plant in New Jersey, which is the company’s only facility making generics for the United States.

All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches that the agency believed could compromise the quality of medicines.

Rival Indian drugmaker Sun Pharmaceutical Industries Ltd agreed to buy Ranbaxy last month in a $3.2 billion deal, betting it can fix Ranbaxy’s problems.

The FDA classified the recall by Ohm Labs as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.

Ranbaxy did not immediately respond to requests for comment.

(Reporting by Zeba Siddiqui in MUMBAI; Editing by Subhranshu Sahu)

Recent Headlines

in Sports

WATCH: Kevin Garnett’s biggest fan

Fresh
10-overlay

On the night of KG's return to the Minnesota Timberwolves, one longtime fan was turning heads.

in Lifestyle

NY couple married 82 years celebrates joint birthday

Fresh
17-overlay1

Duranord Veillard turned 108 on Saturday and his wife, Jeanne will be 105 in May.

in National

Survey: Parents increasingly ask doctors to delay vaccines

Fresh
needle2

Physicians worry that makes under-vaccinated kids and others vulnerable to preventable diseases.

in Sports

Aaron Hernandez trial delayed again due to snow

Fresh
hernandez

There has already been five "snow days" since the trial began Jan. 9.

in National

Homeland Security funding deal elusive

Fresh
homeland

Homeland Security faces another possible shutdown this week.